0001437749-23-000173.txt : 20230103 0001437749-23-000173.hdr.sgml : 20230103 20230103161126 ACCESSION NUMBER: 0001437749-23-000173 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anderson Raymond CENTRAL INDEX KEY: 0001362489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 23502196 MAIL ADDRESS: STREET 1: C/O MONOPAR THERAPEUTICS INC. STREET 2: 1000 SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 rdgdoc.xml FORM 4 X0306 4 2022-12-31 0001645469 Monopar Therapeutics MNPR 0001362489 Anderson Raymond 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 1 Common Stock 2022-12-31 4 M 0 2859 A 16730 D Restricted Stock Units 2022-12-31 4 M 0 2859 0 D Common Stock 2859 0 D Represents shares acquired on vesting and settlement of restricted stock units. On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto, Attorney-in-fact 2023-01-03